Citation Impact
Citing Papers
TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
2015
CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer
2015
Rescue of exhausted CD8 T cells by PD-1–targeted therapies is CD28-dependent
2017 Science
The BRAF and MEK Inhibitors Dabrafenib and Trametinib: Effects on Immune Function and in Combination with Immunomodulatory Antibodies Targeting PD-1, PD-L1, and CTLA-4
2015
MYC regulates the antitumor immune response through CD47 and PD-L1
2016 Science
The Immune Microenvironment Confers Resistance to MAPK Pathway Inhibitors through Macrophage-Derived TNFα
2014
CSF1/CSF1R Blockade Reprograms Tumor-Infiltrating Macrophages and Improves Response to T-cell Checkpoint Immunotherapy in Pancreatic Cancer Models
2014
PD-L1 Expression in Melanocytic Lesions Does Not Correlate with the BRAF V600E Mutation
2014
The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins
2019 StandoutNobel
Anti–CTLA-4 therapy broadens the melanoma-reactive CD8 + T cell response
2014
Ferroptosis regulation by the NGLY1/NFE2L1 pathway
2022 StandoutNobel
CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
2015
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
The complex relationship between TFEB transcription factor phosphorylation and subcellular localization
2018
A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis
2019
A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity
2019
Engineered receptors for soluble cellular communication and disease sensing
2024 StandoutNatureNobel
Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma
2020
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
The urgent need to recover MHC class I in cancers for effective immunotherapy
2016
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
A view on drug resistance in cancer
2019 StandoutNature
Prominin2 Drives Ferroptosis Resistance by Stimulating Iron Export
2019
The role of myeloid cells in cancer therapies
2016
Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
2015
Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
2015
The T-box factor MLS-1 acts as a molecular switch during specification of nonstriated muscle in C. elegans
2002 StandoutNobel
The biology and management of non-small cell lung cancer
2018 StandoutNature
VISTA is an inhibitory immune checkpoint that is increased after ipilimumab therapy in patients with prostate cancer
2017 StandoutNobel
Wnt signaling in cancer
2016 Standout
Targeting Ferroptosis to Iron Out Cancer
2019 Standout
Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy
2016
The chemical basis of ferroptosis
2019
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion
2019
A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells
2006 Standout
Colony stimulating factor 1 receptor inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization
2015
RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
2016
Biological Functions of Autophagy Genes: A Disease Perspective
2019 Standout
PRDM16 controls a brown fat/skeletal muscle switch
2008 StandoutNature
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
2015
A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA
2011 Standout
Exogenous Monounsaturated Fatty Acids Promote a Ferroptosis-Resistant Cell State
2019
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
2015
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Targeting apoptosis in cancer therapy
2020 Standout
The evolution of checkpoint blockade as a cancer therapy: what's here, what's next?
2015
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Glycogen synthase kinase 3β inhibitors prevent hepatitis C virus release/assembly through perturbation of lipid metabolism
2017 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
2017
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Role of GPX4 in ferroptosis and its pharmacological implication
2018
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis
2019 StandoutNature
SIRT3, a Mitochondrial NAD+-Dependent Deacetylase, Is Involved in the Regulation of Myoblast Differentiation
2014
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
2014
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
The PI3K Pathway in Human Disease
2017 Standout
Ferroptosis, radiotherapy, and combination therapeutic strategies
2021
Macrophages and Therapeutic Resistance in Cancer
2015
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Large Scale Gene Expression Analysis of Osteoclastogenesisin Vitro and Elucidation of NFAT2 as a Key Regulator
2002
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Combination immunotherapy: a road map
2017
Macrophage IL-10 Blocks CD8+ T Cell-Dependent Responses to Chemotherapy by Suppressing IL-12 Expression in Intratumoral Dendritic Cells
2014
Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy
2017
Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
2018
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
2016
China’s response to a national land-system sustainability emergency
2018 StandoutNature
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Expression profiling and identification of novel genes involved in myogenic differentiation
2003
TFEB at a glance
2016
Rapid activation of tumor-associated macrophages boosts preexisting tumor immunity
2018
Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation
2004
The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
2016
The Hallmarks of Ferroptosis
2018
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
2018
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p
2017
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
2014
Spermidine in health and disease
2018 StandoutScience
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The Metabolic Underpinnings of Ferroptosis
2020
Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
Molecular Mechanisms RegulatinG Th1 Immune Responses
2003
Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression
2002 Standout
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Neoantigens in cancer immunotherapy
2015 StandoutScience
Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer
2005 Standout
Precise T cell recognition programs designed by transcriptionally linking multiple receptors
2020 Science
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
2015
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Works of Lídia Robert being referenced
Improved antitumor activity of immunotherapy with BRAF and MEK inhibitors in BRAF V600E melanoma
2015
Inhibition of CSF-1 Receptor Improves the Antitumor Efficacy of Adoptive Cell Transfer Immunotherapy
2013
Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
2014
CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
2014
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
2016
Combining targeted therapy with immunotherapy. Can 1+1 equal more than 2?
2016
Anti–PD-1 Therapy in Melanoma
2015
Distinct immunological mechanisms of CTLA-4 and PD-1 blockade revealed by analyzing TCR usage in blood lymphocytes
2014
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
2018
Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges
2014
Molecular mechanisms regulating myogenic determination and differentiation
2000
MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells
2015